NovaPlex HPV28
Closed Solicitation Posted
- Solicitation number
- 2026-95234
- Agency
-
CDC Office of Acquisition Services
Centers for Disease Control and Prevention, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 54138 Testing Laboratories and Services
- Place of performance
- Georgia 30341, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Centers for Disease Control and Prevention (CDC), under the Department of Health and Human Services, is procuring Novaplex HPV28 detection laboratory tests through a sole source procurement under FAR part 13.103-1 (SAP). The intended contractor is Seegene USA, Inc., located in Irvine, California. This is not a competitive solicitation; however, firms believing they can provide the required services are encouraged to submit written notification to the Contracting Officer within 10 days of the publication date (by March 15, 2026) to express their capability. The Government will evaluate any responses received solely to determine whether to conduct a competitive procurement, though the final decision to compete or remain sole source rests exclusively with the Government. Inquiries regarding this opportunity may be directed to Phil Alexander at the CDC Office of Acquisition Services via facsimile at 770-488-2067 or email at PALEXANDER@CDC.GOV.
This procurement carries no set-aside designation and is intended as a sole source award to Seegene USA, Inc. The contract involves the provision of HPV28 laboratory test services, which fall under the Testing Laboratories and Services NAICS category (54138) and the Analysis Instruments, Medical Laboratory Use PSC category (6632). The place of performance is identified as Chamblee, Georgia 30341. No specific award value, budget range, or quantity of tests has been disclosed in this solicitation notice, and no timeline for service delivery or contract duration has been specified in the documentation provided.
Notice text
The Centers for Disease Control and Prevention (CDC) intends to award, on a sole source basis, a purchase/delivery order to: Seegene USA, Inc, 141 Innovation Drive Ste 200, Irvine, CA 92617. The order is for the Novaplex HPV28 Detetion Laboratory Tests. The authority for this sole source procurement is FAR part 13.103-1 (SAP). The contractor shall, provide HPV28 laboratory test.
This is not a request for competitive proposals and no solicitation is available. Firms that believe they can provide the required services are encouraged to identify themselves and give written notification to the Contracting Officer within 10 days from the publication date of this synopsis. A determination by the Government not to compete this proposed action based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. Inquiries may be sent to Phil Alexander by facsimile at 770-488-2067, or by email to PALEXANDER@CDC.GOV.
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Notice of Intent to Sole Source a Thermo Orbitrap Fusion Lumos and Thermo RSLCnano UPLC Maintenance Agreement | CDC Office of Acquisition Services | No set-aside | |
| NCI 2026 Cervical Cancer Screening Follow-Up | National Cancer Institute | No set-aside | |
| 6640--karius test | Veterans Integrated Service Network 8 | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity